Kolexia
Danays Thierry Médecine générale
Danays Thierry
Médecine générale
Boehringer Ingelheim France
Paris, France
24 Activités
1 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infarctus du myocarde Infarctus Infarctus du myocarde avec sus-décalage du segment ST Hémorragie Accident vasculaire cérébral Hypertension artérielle Embolie Embolie pulmonaire Hémorragies intracrâniennes

Collaborateurs

Voir plus
Goldstein Patrick
Goldstein Patrick
Agence Regionale De Sante Hauts-de-france, Lille, France
Lambert Yves
Lambert Yves
Cabinet libéral, Compiègne, France
Bouvaist Helene
Bouvaist Helene
Hôpital Nord Grenoble, La Tronche, France
Meneveau Nicolas
Meneveau Nicolas
Hôpital Jean-Minjoz, Besançon, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Six years of the Angels Initiative: Aims, achievements, and future directions to improve stroke care worldwide.
International journal of stroke : official journal of the International Stroke Society   02 août 2023
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
Circulation   13 juillet 2023
STREAM-2: STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
Essai Clinique (KU Leuven)   20 décembre 2022
PEITHO: Comparison Trial Evaluating Efficacy and Safety of Single i.v. Bolus Tenecteplase Plus Standard Anticoagulation as Compared With Standard Anticoagulation in Normotensive Patients
Essai Clinique (Assistance publique – Hôpitaux de Paris)   06 novembre 2020
Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data.
Stroke   02 juillet 2020
The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients.
American heart journal   15 mai 2020
Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" Am Heart J 169/6 (2015) 890-898.
American heart journal   20 novembre 2019
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction: STREAM (Strategic Reperfusion Early After Myocardial Infarction). Comparison of the Efficacy and Safety of a Strategy of Early Fibrinolytic Treatment With Tenecteplase and Additional Antiplatelet and Antithrombin Therapy Followed by Catheterisation Within 6-24 Hours or Rescue Coronary Intervention Versus a Strategy of Standard Primary PCI in Patients With Acute Myocardial Infarction Within 3 Hours of Onset of Symptoms
Essai Clinique (Boehringer Ingelheim)   06 juin 2019
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial.
Clinical research in cardiology : official journal of the German Cardiac Society   18 décembre 2018
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
Journal of the American College of Cardiology   10 juillet 2017